scispace - formally typeset
E

Ennio Tasciotti

Researcher at Houston Methodist Hospital

Publications -  216
Citations -  9469

Ennio Tasciotti is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Drug delivery & Tissue engineering. The author has an hindex of 42, co-authored 212 publications receiving 7526 citations. Previous affiliations of Ennio Tasciotti include University of Akron & Open University.

Papers
More filters
Journal ArticleDOI

Effects of the protein corona on liposome-liposome and liposome-cell interactions.

TL;DR: In an attempt to better understand the interactions between nanocarriers and biological systems, the plasma proteins adsorbed on the surface of multicomponent liposomes were analyzed and the physical properties and ultrastructure of liposome/PC complexes and the aggregation process that occurs whenliposomes are dispersed in plasma were analyzed.
Journal ArticleDOI

A biomimetic 3D model of hypoxia-driven cancer progression.

TL;DR: This biomimetic model mimics the evolution of tumors with different grade of aggressiveness fostered by a hypoxic niche and provides a relevant technology to dissect the events involved in cancer progression.
Journal ArticleDOI

Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation.

TL;DR: A simple and versatile method to transiently overexpress the hyaluronic acid (HA) receptor, CD44, on MSC membranes, to improve their homing potential towards an inflammatory site without affecting their behavior is reported.
Journal ArticleDOI

Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma.

TL;DR: The use of leukosomes is reported to target and deliver doxorubicin, a model chemotherapeutic, to tumors in syngeneic murine models of breast cancer and melanoma models, demonstrating the promise of using biomimetic nanovesicles for effective cancer management in solid tumors.
Journal ArticleDOI

Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat

TL;DR: It is reported that fusion of TK to an 11-amino-acid peptide from the basic domain of the HIV-1 Tat protein (Tat11) imparts cell membrane translocating ability to the enzyme and significantly increases its cytotoxic efficacy.